Your session is about to expire
← Back to Search
Islet Transplantation for Type 1 Diabetes
Study Summary
This trial will study whether islet cell transplantation can help people with type 1 diabetes who have trouble controlling their blood sugar, despite using standard insulin therapy and monitoring their blood sugar levels often.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a high body mass index (BMI).I am on long-term medication for a chronic illness.I currently have an ongoing infection.You have a high level of preformed antibodies in your blood.My liver is healthy.I have had Type 1 diabetes for over 5 years and it's hard to control.I check my blood sugar at least four times a day and keep detailed records.I often have low blood sugar episodes that I can't feel or that need help.I am between 18 and 65 years old.I have a serious heart condition.I am not pregnant, breastfeeding, and I am willing to use effective contraception.I am at a higher risk of bleeding or I am on long-term blood thinners.I do not have an untreated mental health condition that could affect a transplant.I can follow the treatment plan after my transplant, including taking medications, using an insulin pump, and undergoing tests.My cholesterol levels are high despite treatment.You need to use a device that measures your blood sugar levels over time to see if you have episodes of low or high blood sugar often.I have struggled to follow strict blood sugar control and insulin pump guidelines recently.I have anemia or another blood disorder that needs treatment.You are currently using alcohol, drugs, or smoking cigarettes regularly.My kidneys are functioning well without significant protein loss.I have a serious liver condition.I have had cancer before, but it was only skin cancer or cervical cancer that did not spread.
- Group 1: 1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available for volunteers in this experiment?
"This clinical trial, which was originally created on April 7th 2004 and last modified on July 6th 2022, is not presently recruiting. Despite this, a plethora of other trials are currently looking for applicants - 1250 to be exact."
Does this research endeavor accept participants aged under 80?
"Patients seeking enrollment in this clinical trial must be between 18 and 65 years of age. If somebody is younger than 18 they can look at the 217 studies that cater to minors, while those older than 65 may find a more suitable fit amongst the 917 trials tailored for senior citizens."
Has the FDA approved Islet cell transplantation for patient treatment?
"The team at Power has evaluated the safety of Islet cell transplantation as a 1, due to it being in its early phases and having only minimal data corroborating safety and efficacy."
Could I be considered a suitable participant for this clinical research?
"To be eligible for this trial, individuals must have diabetes mellitus and fall within the ages of 18-65. Additionally, only 17 participants are needed for enrollment."
Share this study with friends
Copy Link
Messenger